Literature DB >> 29272533

Wildflowers abundant in the garden of systemic sclerosis research, while hopeful exotics will one day bloom.

Lesley Ann Saketkoo1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29272533      PMCID： PMC5850611          DOI： 10.1093/rheumatology/kex420

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  11 in total

1.  Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Authors:  Veronika K Jaeger; Oliver Distler; Britta Maurer; Laszlo Czirják; Veronika Lóránd; Gabriele Valentini; Serena Vettori; Francesco Del Galdo; Giuseppina Abignano; Christopher Denton; Svetlana Nihtyanova; Yannick Allanore; Jerome Avouac; Gabriele Riemekasten; Elise Siegert; Dörte Huscher; Marco Matucci-Cerinic; Serena Guiducci; Marc Frerix; Ingo H Tarner; Beata Garay Toth; Beat Fankhauser; Jörg Umbricht; Anastasia Zakharova; Carina Mihai; Franco Cozzi; Sule Yavuz; Nicolas Hunzelmann; Simona Rednic; Alessandra Vacca; Tim Schmeiser; Valeria Riccieri; Paloma García de la Peña Lefebvre; Armando Gabrielli; Brigitte Krummel-Lorenz; Duska Martinovic; Codrina Ancuta; Vanessa Smith; Ulf Müller-Ladner; Ulrich A Walker
Journal:  Rheumatology (Oxford)       Date:  2018-03-01       Impact factor: 7.580

2.  Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis.

Authors:  Janine Giese-Davis; Kate Collie; Kate M S Rancourt; Eric Neri; Helena C Kraemer; David Spiegel
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

3.  Quality of life independently predicts long-term mortality but not vascular events: the Northern Manhattan Study.

Authors:  John W Liang; Ying Kuen Cheung; Joshua Z Willey; Yeseon P Moon; Ralph L Sacco; Mitchell S V Elkind; Mandip S Dhamoon
Journal:  Qual Life Res       Date:  2017-03-29       Impact factor: 4.147

4.  Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.

Authors:  Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

Review 5.  Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival.

Authors:  Kelly E Irwin; Joseph A Greer; Jude Khatib; Jennifer S Temel; William F Pirl
Journal:  Chron Respir Dis       Date:  2013-02       Impact factor: 2.444

Review 6.  International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative.

Authors:  Lesley Ann Saketkoo; Reuben Escorpizo; Kevin J Keen; Kim Fligelstone; Oliver Distler
Journal:  Rheumatology (Oxford)       Date:  2012-08-23       Impact factor: 7.580

7.  [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].

Authors:  P Ostuni; C Botsios; P Sfriso; A Bertagnin; F Cozzi; A Doria; S Todesco
Journal:  Minerva Med       Date:  2002-06       Impact factor: 4.806

8.  Health-related quality of life predicts mortality in patients with advanced chronic liver disease.

Authors:  Fasiha Kanwal; Ian M Gralnek; Ron D Hays; Angelique Zeringue; Francisco Durazo; Steven B Han; Sammy Saab; Roger Bolus; Brennan M R Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-21       Impact factor: 11.382

9.  Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

Authors:  Jacob M van Laar; Dominique Farge; Jacob K Sont; Kamran Naraghi; Zora Marjanovic; Jérôme Larghero; Annemie J Schuerwegh; Erik W A Marijt; Madelon C Vonk; Anton V Schattenberg; Marco Matucci-Cerinic; Alexandre E Voskuyl; Arjan A van de Loosdrecht; Thomas Daikeler; Ina Kötter; Marc Schmalzing; Thierry Martin; Bruno Lioure; Stefan M Weiner; Alexander Kreuter; Christophe Deligny; Jean-Marc Durand; Paul Emery; Klaus P Machold; Francoise Sarrot-Reynauld; Klaus Warnatz; Daniel F P Adoue; Joël Constans; Hans-Peter Tony; Nicoletta Del Papa; Athanasios Fassas; Andrea Himsel; David Launay; Andrea Lo Monaco; Pierre Philippe; Isabelle Quéré; Éric Rich; Rene Westhovens; Bridget Griffiths; Riccardo Saccardi; Frank H van den Hoogen; Willem E Fibbe; Gérard Socié; Alois Gratwohl; Alan Tyndall
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272

10.  Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Authors:  Donald P Tashkin; Michael D Roth; Philip J Clements; Daniel E Furst; Dinesh Khanna; Eric C Kleerup; Jonathan Goldin; Edgar Arriola; Elizabeth R Volkmann; Suzanne Kafaja; Richard Silver; Virginia Steen; Charlie Strange; Robert Wise; Fredrick Wigley; Maureen Mayes; David J Riley; Sabiha Hussain; Shervin Assassi; Vivien M Hsu; Bela Patel; Kristine Phillips; Fernando Martinez; Jeffrey Golden; M Kari Connolly; John Varga; Jane Dematte; Monique E Hinchcliff; Aryeh Fischer; Jeffrey Swigris; Richard Meehan; Arthur Theodore; Robert Simms; Suncica Volkov; Dean E Schraufnagel; Mary Beth Scholand; Tracy Frech; Jerry A Molitor; Kristin Highland; Charles A Read; Marvin J Fritzler; Grace Hyun J Kim; Chi-Hong Tseng; Robert M Elashoff
Journal:  Lancet Respir Med       Date:  2016-07-25       Impact factor: 30.700
View more
  4 in total

Review 1.  Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases.

Authors:  Lesley Ann Saketkoo; John D Pauling
Journal:  Rheum Dis Clin North Am       Date:  2018-02-21       Impact factor: 2.670

Review 2.  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors:  Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-09-15       Impact factor: 4.991

Review 3.  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

Authors:  Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-07-01       Impact factor: 4.991

4.  Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials.

Authors:  Lesley Ann Saketkoo; Mary Beth Scholand; Matthew R Lammi; Anne-Marie Russell
Journal:  J Scleroderma Relat Disord       Date:  2020-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.